Treatment for vaginal infections based on basil essential oil

Basil essential oil could soon be counted among the natural treatments for vaginal infections. According to a new study, the oil contains compounds capable of eradicating pathogens while respecting the balance of the vaginal microbiota. 

Vaginal infections Vaginal infections Vaginal yeast infection

Basil extracts have powerful antimicrobial effects that could be used to restore imbalances in the vaginal flora responsible for bacterial vaginosis and vulvovaginal candidiasis (vaginal yeast infection). These were the findings of a study recently carried out in Korea. 1

Fragile but precious vaginal lactobacilli

The vagina is home to a microbiota composed of several hundred bacterial species and a small number of fungi, including yeasts of the genus Candida. All of them contribute to maintaining a healthy environment. For example, lactobacilli secrete lactic acid, which acidifies the vaginal environment (maintaining a pH between 3.8 and 4.5), thereby helping to keep many pathogenic microorganisms at bay.

When the natural acidity of the vagina is disrupted or lactobacilli become depleted, an imbalance (dysbiosis) can develop, promoting proliferation of microorganisms associated with bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), i.e. vaginal yeast infections (see box).

Bacterial vaginosis vs. vulvovaginal candidiasis: what are the differences?

Bacterial vaginosis 

  • Cause: abnormal proliferation of pathogenic bacteria (Gardnerella vaginalis, Fannyhessea vaginae, Chryseobacterium gleum, etc.) and a decrease in Lactobacillus. 
  • Prevalence: one quarter of women affected. 2
  • Symptoms: unusual and foul-smelling vaginal discharge, itching, irritation, and a burning sensation when urinating.
     

Vaginal yeast infection (vulvovaginal candidiasis)

  • Cause: abnormal proliferation of Candida albicans, a fungus naturally present in the vaginal flora. 
  • Prevalence: 75% of women affected at some point in their lives. 3
  • Symptoms: itching, irritation, burning sensation, and abnormal vaginal discharge.

Search for alternative treatments

These infections are often still treated with antimicrobials, such as antibiotics or antifungals. However, the overuse of these treatments promotes the emergence of resistant bacteria and fungi and can affect populations of vaginal lactic acid bacteria, thereby weakening the vaginal microbiota.

Are there any effective and microbiota-friendly therapeutic alternatives to treat and prevent vaginal infections? A team of Korean researchers sought to answer this question by studying basil.

Basil, a traditional remedy for infections

Basil (Ocimum basilicum L.) is a medicinal plant traditionally used as a folk remedy in many cultures to treat respiratory infections, and has been shown to have powerful antibacterial effects due to its high content of bioactive compounds.

To assess its impact on vaginal microorganisms, the scientists tested the effect of various fractions of basil essential oil on in vitro cultures of the microorganisms involved in vaginitis: Gardnerella vaginalis, Fannyhessea vaginae, Chryseobacterium gleum, and Candida albicans.

Their results show that basil essential oil, even at low concentrations, has powerful antimicrobial effects against the four pathogens tested, without showing any toxicity to beneficial lactobacilli (Lactobacillus crispatus) or skin cells (dermal fibroblasts). 
 

Basil, proven potential against infections

Several studies have examined the antimicrobial properties of basil essential oil. It has proven potential against:

  • Urinary tract infections: acts against Escherichia coli, Enterococcus spp. and Candida albicans 4;
  • Respiratory and pulmonary infections: disrupts bacteria involved in pneumonia (Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, etc.) 5;
  • Hospital-acquired infections: hinders multi-resistant strains of E. coli in patients with respiratory, urinary, skin, and other infections 6;
  • Candidiasis: blocks Candida albicans by disrupting its metabolism and membrane integrity. 7

Never use undiluted on the skin! Talk to a health professional.

Synergistic effect

A particular compound, called methyl trans-cinnamate, appears to explain some of these effects, but the researchers suspect a synergy exists between different molecules present in basil essential oil.

While these findings are encouraging, they relate solely to laboratory tests. Effectiveness as a treatment—and above all safety—still needs to be confirmed by clinical studies in women. In the meantime, avoid self-medication and seek advice from your doctor or pharmacist. While plants continue to be an interesting avenue of research, they are not a substitute for recommended treatments.

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

This one gut microbe could change the way cancer therapy performs

A single gut microbe may influence whether a patient responds to cancer immunotherapy. This study reveals how signals from the intestine can strengthen the body’s antitumour defences in ways we never expected.

Immunotherapy is rewriting oncology, but in most solid tumours, (sidenote: PD-1 inhibitors Drugs that release the “brakes” on T cells by blocking the PD-1 receptor, allowing the immune system to attack tumours more effectively. ) still fail the majority of patients. Our story starts in a place every clinician knows matters but few can yet “dose”: the gut microbiome. Oncologists have seen that some patients ride a wave of durable response to treatment, while others, seemingly similar on paper, barely respond at all. A new study published in Nature 1 asks a simple but profound question: a single gut microbe that can reprogram dendritic cells, send them on a “road trip” from the intestine to the tumour, and make checkpoint inhibitors work better? And the answer appears to be yes.

A hidden player in PD-1 response

Researchers from National Cancer Center Research Institute, Tokyo followed patients with lung and gastric cancer receiving PD-1 blockade and looked at their stool microbiome just before treatment. Responders consistently had richer bacterial diversity and, more specifically, more members of the (sidenote: Ruminococcaceae A family of gut bacteria often linked to a healthier, more diverse microbiome and better immune activation.
 
)
family. From this group they isolated an unassuming anaerobe, a strain of Hominenteromicrobium mulieris they call YB328.

Patients with higher levels of YB328 had longer progression-free survival across several cohorts and cancer types. In contrast, those enriched with a common Bacteroidaceae member, Parabacteroides vulgatus, tended to do worse. When these microbes were moved into mice, the story held: YB328 turned PD-1 therapy into a much more potent anti-tumour tool, while P. vulgatus left tumours largely unbothered.

How one bacterium re-wires dendritic cells

YB328 doesn’t just “boost the immune system.” It changes how key immune cells are made. In both lab and animal studies, this bacterium guides early immune precursors to develop into a specific type of dendritic cell, (sidenote: cDC1 dendritic cells A specialised subset of dendritic cells skilled at presenting antigens and activating strong CD8 T-cell responses against tumours.
 
)
, by turning on the genes that drive this pathway. It uses a set of sensing signals inside these cells to do so.

Once formed, these gut-trained cDC1 cells don’t stay in the intestine. They move step-by-step through the lymphatic system and eventually reach the tumour. Using special mouse models that let researchers track cell movement, the study shows these gut-derived dendritic cells physically entering the tumour environment.
Inside the tumour, they present tumour antigens more effectively, activate more CD8 T cells, and help those T cells recognise a wider range of tumour targets, including weaker signals that would normally be missed. In simple terms, YB328 helps the immune system “see” more of the tumour and respond with greater strength and breadth.

Microbial competition and therapeutic imitation

Equally striking is what happens when ecology works against us. In mice colonized with a “non-responder” microbiome, adding YB328 can rescue PD-1 efficacy, but only if competing strains like P. vulgatus don’t block its (sidenote: Engraftment The successful establishment and persistence of a microbial strain in the gut after it is introduced.
 
)
. One microbe can cancel out another’s benefit, a sobering reminder for any future live biotherapeutic strategy.

Finally, the authors show that a defined cocktail of (sidenote: TLR agonists Molecules that activate Toll-like receptors, stimulating innate immune pathways and boosting immune cell activation. ) can mimic much of YB328’s effect on cDC1 programming and PD-1 synergy. This work reframes the gut not just as a biomarker source, but as a tunable upstream regulator of dendritic cell biology and checkpoint response, opening the door to microbiome-guided or TLR-based adjuvants that might turn more of our “non-responders” into durable responders.

Phage therapy: a new way to restore the effectiveness of chemotherapy

Find out more!
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Oncology Immunotherapy Off

Exposome: understanding how our environment shapes our microbiota

What is the exposome and how does it interact with the human microbiota? In this video series with Dr Véronique Mondain, discover how the exposome connects the microbiota, the body and the environment, and why it is essential for the future of healthcare.

Exposome: exposed microbiota puts health at risk What foods promote a balanced microbiota? The gut microbiota The vaginal microbiota

What if health was more than genetics? What if it was everything we’re exposed to? The exposome represents the sum of all environmental, behavioral, and social factors that influence our biology from conception to death. In this playlist, experts explore how the exposome connects our microbiota, environment, lifestyle, and emotions; offering a new way to understand and prevent chronic diseases. From endocrine disruptors and stress to nutrition, integrative medicine, and early-life exposures, discover how these factors interact to shape health across a lifetime.

Dive into this series to better understand the science behind the exposome and how small, informed changes can make a big difference for global health

Exposome: exposed microbiota puts health at risk 

Go back to the main page

How can we avoid harmful exposures to our health?

Image
Photo: video Youtube exposome 1 - Dr. Véronique Mondain - planet

Modern life is convenient but not always healthy. In this video, discover how everyday choices around food, lifestyle, and environment shape our long-term well-being and the health of future generations.

Through the lens of the exposome, this talk reminds us that true prevention starts with common sense habits: eating real, minimally processed food; moving daily; protecting mental health; and living more consciously for ourselves and for the planet.

You’ll learn:

  • How modern habits and ultra-processed food impact health and inflammation
  • Why balance, simplicity, and mindful consumption matter
  • How early childhood and parenting shape lifelong resilience

Environmental & integrative medicine: a new way of healing?

Image
Photo: video Youtube exposome 1 - Dr. Véronique Mondain - research

Modern healthcare is evolving, moving beyond symptoms to explore how our environment, lifestyle, and mind-body balance influence chronic diseases.

This video explains how environmental medicine (understanding our exposures) and integrative medicine (combining evidence-based non-drug approaches) work together to improve prevention and patient outcomes.

You’ll learn:

  • What environmental and integrative medicine mean in today’s healthcare
  • The science behind validated non-drug practices: nutrition, activity, hypnosis, meditation, and acupuncture
  • How these approaches support cancer, diabetes, obesity, and other chronic conditions

Exposome & health: does gender make a difference?

Image
Photo: video Youtube exposome 1 - Dr. Véronique Mondain - gender

From hormone disruptors to occupational exposures, gender shapes how we interact with our environment and how it impacts our health.

In this video, discover how endocrine disruptors can influence the development of hormone-dependent cancers, early puberty, and reproductive disorders, and why understanding gender-specific exposures is key to protecting future generations.

You’ll learn:

  • How endocrine disruptors impact men, women, and children differently
  • Real-world examples: cosmetics, construction, farming, and beyond
  • Why the exposome must include gender to advance precision prevention

Genome, epigenetics, exposome: how are they different?

Image
Photo: video Youtube exposome 1 - Dr. Véronique Mondain - DNA

Your genes are not your destiny. This video breaks down how genome (your DNA), epigenetics (how gene expression is switched on/off), and the exposome (the totality of life-long exposures) interact to shape health.

From DNA methylation and histones to endocrine disruptors, the microbiota, and windows of vulnerability (like the first 1,000 days), discover how environment and lifestyle orchestrate biology—and why prevention starts with understanding exposures.

You’ll learn:

  • Clear definitions: genome vs. epigenetics vs. exposome
  • How exposures modulate genes and drive low-grade inflammation
  • Practical takeaways to reduce harmful exposures

How to introduce the exposome in consultation?

Image
Photo: video Youtube exposome 1 - Dr. Véronique Mondain - consultation

What if the key to understanding chronic diseases lies in everything we’re exposed to, from stress and diet to pollution and lifestyle?

In this video, Dr. Véronique Mondain, an infectious disease specialist, explains how studying the exposome — the sum of all environmental and behavioral exposures — transforms the way we approach prevention and integrative medicine.

Summary
On
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Anti-inflammatory diet and cognitive impairment: role of the oral and gut microbiota

Anti-inflammatory diets support a healthy oral and gut microbiota, leading to better cognitive performance... and perhaps helping prevent cognitive decline?

Roughly one in six Chinese adults over 60 experience (sidenote: Mild Cognitive Impairment (MCI) MCI is a clinical stage between the expected cognitive decline of normal aging and the more severe decline of dementia. Individuals with MCI have noticeable memory or thinking problems but can still perform most daily activities, representing a critical window for intervention and study. ) , with an annual risk of progression to dementia of 6 to 15% (10 times higher than in people without MCI). How can we act at this stage? Through diet, according to a study that assessed how the inflammatory potential of the diet affects the diversity and composition of the oral and gut microbiota, as well as cognitive performance, in 54 Chinese adults over 60 (36 with MCI and 18 controls without).

15.54% The prevalence of mild cognitive impairment (MCI) among older Chinese people > 60 years of age is approximately 15.54%.

10x The annual conversion rate to dementia ranges from 6 to 15% for Chinese MCI patients, which is about 10 times higher than the conversion rate for cognitively normal older adults.

Diet affects oral diversity

Oral microbiota diversity varies according to the dietary inflammatory score (measured by the (sidenote: E-DII score (Energy-adjusted Dietary Inflammatory Index) An epidemiological tool designed to assess an individual’s overall dietary inflammatory potential by adjusting this score according to total caloric intake, allowing standardized comparison between individuals regardless of energy consumption. ) ); oral microbial richness (measured by the Shannon index) decreases as the inflammatory potential of the diet increases.
However, the inflammatory score does not seem to significantly affect gut microbiota diversity.

Altered microbiota

Microbiota composition also changes. In individuals with an anti-inflammatory diet (tertile T1), the oral abundance of certain bacteria increases 1. Among those following pro-inflammatory diets (T3), the most enriched taxa belong to the genus Lacticaseibacillus.
As for the gut microbiota, two taxa (the family Porphyromonadaceae and its genus Porphyromonas) were more abundant with a pro-inflammatory diet, while some bacteria (including the genera Haemophilus, Holdemanella, and norank.RF39) show reduced abundance.

Associations with cognitive functions

Finally, the authors highlight links between microbiota and cognitive performance (memory, language, attention). For example, in the oral cavity, 3 bacteria typical of anti-inflammatory diets 1 were associated with higher test scores, while the genus Lacticaseibacillus (inflammatory diet) correlated with poorer performance. How can these effects be explained? Eubacterium produces butyrate, a brain-protective anti-inflammatory fatty acid. Lactobacillaceae synthesize acids that cause cavities and systemic inflammation.
In the gut microbiota, the bacterium Haemophilus (inflammatory diet) appears linked to poorer performance, while two other digestive microorganisms, Holdemanella and Porphyromonas, show positive associations with cognition. 

A pro-inflammatory diet may alter gut microbiota composition and trigger an inflammatory response in peripheral circulation and in the central nervous system through a two-way “microbe–gut–brain” communication axis, which could impair cognitive brain function.

Predicting cognitive decline?

Distinct oral and gut microbiota profiles could indicate the onset of disorders. Artificial intelligence models can predict mild cognitive impairment based solely on these microbiota, with moderate accuracy for the oral microbiota ( (sidenote: AUC (Area Under the Curve) A measure of a model’s ability to correctly distinguish between two classes (for example, “diseased” vs “healthy,” “positive” vs “negative”). It represents the area under a curve that plots the true positive rate (sensitivity) on the y-axis against the false positive rate on the x-axis. If the AUC equals 1, the model performs perfectly; above 0.80 it is generally considered very good, and above 0.90, excellent; at 0.5, it performs no better than random chance.
 
)
= 0.75) and high accuracy for the gut microbiota (AUC = 0.87).

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Nutrition Off

Our cognitive health on our plate... and in our microbiota!

Did you think the Mediterranean diet was good only for your heart (and your taste buds)? Good news: it may also nurture your brain, through a rather unexpected path – your oral and gut microbiota!  

The gut microbiota

Vegetables, fruits, nuts, olive oil, fish... the Mediterranean diet, known for its many benefits, could have one more advantage: slowing cognitive decline.
That is what a study 1 of 54 Chinese seniors with or without (sidenote: Mild Cognitive Impairment (MCI) MCI is a clinical stage between the expected cognitive decline of normal aging and the more severe decline of dementia. Individuals with MCI have noticeable memory or thinking problems but can still perform most daily activities, representing a critical window for intervention and study. ) suggests. The study explored the effect of (sidenote: Anti-inflammatory diets Diets characterized by high consumption of fruits, vegetables, whole grains, legumes, fatty fish, nuts, olive oil and phytochemicals, while limiting the intake of foods with potentially pro-inflammatory properties such as red meat, refined carbohydrates and alcohol. The rationale for anti-inflammatory diets (including but not limited to the Mediterranean diet) lies in their capacity to decrease inflammation.

Source: Yu X, Pu H, Voss M. Overview of anti-inflammatory diets and their promising effects on non-communicable diseases. Br J Nutr. 2024 Oct 14;132(7):898-918. doi: 10.1017/S0007114524001405. 
)
, in particular the Mediterranean diet.

15,54 % The prevalence of mild cognitive impairment (MCI) among older Chinese people > 60 years of age is approximately 15.54%. ¹

10x The annual conversion rate to dementia ranges from 6 to 15% for Chinese MCI patients, which is about 10 times higher than the conversion rate for cognitively normal older adults. ¹

When your plate calms inflammation and boosts cognition

The researchers observed that people who follow an anti-inflammatory diet have a more diverse population of oral bacteria, including a higher number of certain “good bacteria” such as Corynebacterium or Eubacterium yurii.
In return for the shelter and food we provide, these bacteria offer major benefits: they produce butyrate, for example, a compound that calms inflammation, protects the brain and supports memory. The same applies to the gut: the microbiota of people consuming anti-inflammatory diets hosts specific bacteria. 
Result of this mouth–gut–brain interconnection: higher cognitive scores on memory, attention and language tests among people who follow anti-inflammatory diets!

What role does the microbiota play in the gut-brain axis?

Learn more

When your plate sparks inflammation, your brain takes the hit

In contrast, fans of diets high in saturated fat and low in fruits and vegetables (in short, pro-inflammatory diets) showed a decrease in oral bacterial diversity.

1.5

Humans swallow 1 to 1.5 liters of saliva daily, serving as a conduit for billions of oral bacteria. 2

Less friendly bacteria such as Lacticaseibacillus took over. The problem: some of them are known to produce acids that cause cavities and trigger systemic inflammation, a factor linked to cognitive decline.
The same goes for gut microbiota: inflammatory diets promote bacteria associated with lower cognitive performance and weaken the microorganisms that could have boosted it.

Result: unimpressive cognitive scores for lovers of junk food!

Could your microbiota predict your brain’s future?

The researchers went even further: they used artificial intelligence models to test whether microbiota could predict the risk of cognitive impairment. And it worked!
Using the gut microbiota data alone, they predicted cases of mild cognitive impairment with 87% accuracy. Not bad for a test based only on your gut flora!

Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Off

Gut–mind–pelvic axis: new insights from microbiome science

What if the microbes in a woman’s gut and vagina could predict her stress, sexual well-being, or recovery from cancer? A new study reveals the microbiome isn’t just a passenger, it may be an unseen driver of quality of life in endometrial disease.

Doctors treating endometrial cancer often focus on surgery, hormones, and tumor grade. But what if the microbes living in a patient’s body are quietly shaping how she feels, her stress levels, digestion, and even sexual interest? A new study from researchers at the University of Oklahoma turns that question into data 1. They followed 140 women scheduled for hysterectomy, some with endometrial cancer (EC, n=47), others with benign gynecologic conditions such as fibroids or endometriosis (n=93).

Before surgery, each woman completed validated surveys assessing mental and physical health, GI symptoms, stress, sexual function, and vaginal comfort. At the same time, scientists collected vaginal and rectal swabs for microbiome sequencing. The goal: connect quality-of-life metrics to microbial fingerprints across two key body sites.

The microbial paradox of endometrial cancer

Here’s where things got surprising. In most healthy women, low vaginal diversity, dominated by protective Lactobacillus crispatus species, is considered a sign of balance. But in this study, endometrial cancer patients showed the opposite pattern: they had higher (sidenote: Vaginal microbial diversity Refers to the variety and balance of bacterial species living in the vagina. Changes in this diversity can influence symptoms like dryness, irritation, and infection risk.
 
)
, and the more diverse their microbiome, the worse their vaginal dryness and irritation. Even more unexpected, (sidenote: Lactobacillus iners A less protective vaginal bacterium that produces only L-lactic acid, often associated with microbial imbalances and vulnerability to opportunistic infections ) , often thought of as not very “friendly”, was enriched in women reporting worse symptoms, alongside Lactobacillus gasseri, and Streptococcus agalactiae, a rather “friendly” vaginal bacteria. In short, microbes that normally spell health appeared to coincide with discomfort in this cancer population, suggesting that the rules of vaginal ecology may shift under oncologic conditions.

The gut–mind–pelvic connection

The rectal microbiome also told an intriguing story. In women with EC, certain gut bacteria, especially (sidenote: Gastranaerophilales An order of gut bacteria that, in this study, was associated with better mental health and reduced stress in women with endometrial cancer. It’s thought to play a role in gut–brain communication and metabolic balance. ) , were linked to better mental health, lower stress, and improved physical well-being. Others, such as (sidenote: Christensenellales A family of gut microbes often associated with healthy metabolism and reduced inflammation. Here, its presence correlated with less bloating and gastrointestinal discomfort. ) and Desulfovibrionales, correlated with less bloating. Conversely, Veillonellales were tied to more gas and discomfort in women with benign conditions. Even sexual interest bore a microbial signature: vaginal Porphyromonas and Campylobacter were associated with lower libido, while Dialister appeared in women reporting higher sexual interest. These cross-links hint at a real (sidenote: Gut–brain–pelvic axis A concept describing the interconnected communication between the gut microbiome, the brain, and the reproductive organs. It suggests that microbial changes in the gut or vagina can influence mood, stress, and sexual health. ) , a biological dialogue connecting microbiota, mood, and intimate health.

Rethinking the role of microbes in cancer care

What makes this study stand out is its integration of patient experience with molecular biology, a rare bridge between the clinic and the lab. Rather than viewing the microbiome as a passive bystander, the data suggest it may be an active participant in symptom expression and recovery. In the future, mapping these microbial patterns could help predict which patients are most likely to struggle with vaginal or gastrointestinal side effects during cancer treatment, or whose emotional well-being might be at risk.

It also opens the door to precision microbiome interventions, from targeted probiotics to dietary strategies, designed not just to fight disease, but to restore comfort, intimacy, and resilience in women navigating endometrial cancer and its aftermath. As the lead authors put it, the microbes of the vagina and gut may soon become “vital signs” of how a woman feels, not just what disease she carries.

Women’s Microbiome 1 - September 2025

Discover now!
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Gynecology Off

Before the brain declines, the gut speaks first: Microbiome clues to multiple sclerosis progression

Before multiple sclerosis progresses, the gut may whisper its warning. New research reveals that specific microbes and their metabolites vanish years before neurodegeneration accelerates, offering clinicians a metabolic early-warning system.

Neurological disorders

For decades, multiple sclerosis (MS) has been understood as a disease of the immune and nervous systems, a chronic battle of inflammation and neurodegeneration. But in recent years, evidence has been mounting that the gut microbiome may be a silent third player, influencing how patients respond to therapy, experience fatigue, and ultimately, how their disease evolves. Still, one question has remained unanswered: can gut microbes actually predict who will worsen?

A new longitudinal study from Laura Cox and Howard Weiner at Harvard Medical School, published in Cell Reports Medicine1, brings us closer to that answer. Using the Comprehensive Longitudinal Investigation of Multiple Sclerosis (CLIMB) cohort, the team followed 192 people with MS over two years, pairing stool and serum metabolomics with MRI scans, cognitive tests, and quality-of-life data. Their goal was to find the microbial and metabolic fingerprints that appear just before patients transition from relapsing to progressive MS.

Gut brain axis: how your microbiota talks to your brain?

Learn more

The missing microbes of stability

Among those whose disability worsened, several beneficial microbes had quietly disappeared. Eubacterium hallii, Butyricicoccus, and Blautia, all key producers of anti-inflammatory metabolites, were markedly reduced. In contrast, Alistipes onderdonkii and Bacteroides vulgatus expanded, tracking with higher MRI-detected brain atrophy and cognitive decline. Although these beneficial microbes are known to produce (sidenote: Short chain fatty acids (SCFA) Short chain fatty acids (SCFA) are a source of energy (fuel) for an individual’s cells. They interact with the immune system and are involved in communication between the intestine and the brain. Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. ) like butyrate, the study found no change in SCFA levels. This implies that their role extends well beyond fiber fermentation. These species may shape immune and neural signaling through bile acid conversion, lipid modulation, and vitamin biosynthesis, a more complex and far-reaching mechanism than previously appreciated.

A metabolic fingerprint of progression

In patients who transitioned to progressive MS, the gut’s chemical landscape was profoundly altered. Stool metabolites with neuroprotective potential, such as nicotinate (vitamin B3), pyridoxamine (vitamin B6), and protoporphyrin IX, fell sharply. Meanwhile, blood levels of palmitoleate and p-cresol sulfate, molecules linked to neuroinflammation and myelin toxicity, rose. Even secondary bile acids like ursodeoxycholate, known for calming neuroinflammatory cascades, were depleted.

The picture that emerges is one of metabolic silence. In essence, the microbes capable of making protective compounds, especially Akkermansia and Eubacterium hallii, fade away just as neurodegeneration accelerates. The result is a gut that can no longer send restorative chemical signals to the brain.

A clinical application?

Imagine adding microbiome screening to annual checkups for patients with relapsing-remitting MS - tracking the abundance of protective species or the loss of bile-acid producers as an early alert that the disease is changing course. This kind of “gut signature monitoring” could one day guide treatment intensity, rehabilitation planning, or nutritional interventions.
The therapeutic implications are equally compelling. If specific microbial metabolites, like vitamin B3, B6 derivatives, or secondary bile acids, act as neuroprotective agents, dietary supplementation or next-generation probiotics could restore that lost metabolic communication. The goal wouldn’t be to replace immunotherapy but to add a gut-targeted layer of (sidenote: Neuroprotection The preservation of neuronal structure and function against injury or degeneration. In the context of MS, neuroprotective strategies aim to prevent the loss of axons and myelin. The study suggests that certain microbial metabolites, such as vitamin B3, B6 derivatives, and bile acids, may exert neuroprotective effects, positioning the gut as a potential therapeutic target to slow disease progression. ) , helping patients preserve function longer.

In the coming years, as microbiome assays become cheaper and more standardized, it’s not hard to imagine a clinical future where neurologists, dietitians, and microbiome specialists work side by side, using microbial data to keep MS quiet, one gut metabolite at a time.
 

Everything you need to know about the microbiota gut-brain axis

Find out more!
Summary
Off
Sidebar
On
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
News Neurology Off

Live probiotic coconut yogurt, is it worth recommending?

By Dr. Hanna Stolińska
Dietetic Clinic, Warsaw, Poland 

Health influencers on social media are buzzing about a super-live probiotic coconut yogurt claiming to revolutionize gut health. Marketed as a superfood packed with billions of probiotics, it has gained a cult-like following among wellness enthusiasts. Fans praise its supposed benefits, from improved digestion to healthier skin, but what does science have to say compared to traditional probiotics? Is this coconut-derived probiotic-rich formula a true microbiome booster or just another overhyped wellness trend?

What is inside the probiotic coconut-based yogurt?

The coconut-based yogurt is made from organic coconut meat and coconut water, fermented with 16 custom probiotic strains, including Lactobacillus acidophilus, Bifidobacterium breve, and Streptococcus thermophilus.

What health benefits does it claim to offer? Is it truly beneficial for health?

It is reported online that consuming this yogurt may improve digestion, reduce bloating, promote healthier skin, and strengthen the immune system. While probiotics can offer health benefits, scientific evidence specifically supporting this yogurt’s claim remains limited.

We know that coconut flesh is mainly composed of lipids and such yogurt provides very little protein. On top of that coconut oil is used as a cure for all sorts of ailments, such as fighting viruses and bacteria, supporting immunity, reducing cholesterol, supporting thyroid function, and even weight loss 1-4.

Coconut oil contains medium-chain triglycerides (MCT) fatty acids, which are more easily digested and less absorbed compared to longer-chain fatty acids. However, of all the saturated fatty acids in coconut oil, MCTs constitute only half. Some MCTs, such as lauric acid and capric acid, have antifungal and antiviral properties 1-3, but the purpose of consuming food is to provide components that strengthen the immune system, which then fights microbes 4.

How does it impact the gut microbiota?

This probiotic-enriched yogurt contains live bacteria that can potentially influence gut microbiota. However, the effectiveness of probiotics depends on various factors, including the specific strains used, their ability to survive stomach acid, and the individual’s existing gut microbiome composition.

Some studies suggest that mediumchain triglycerides (MCTs), found in coconut, may affect microbiome composition. However, research on probiotic coconut-based products is still in its early stages. Moreover, while coconut oil contains antimicrobial compounds like lauric acid (converted into monolaurin in the body), this does not necessarily translate into overall gut health benefits 1, 3.

An interesting rat study investigating different dietary oils’ effects on gut microbiota found that coconut oil consumption led to reduced bacterial diversity, increased markers of metabolic endotoxemia, fatty liver disease, and higher LDL cholesterol levels 5. While animal studies provide insight, further clinical trials in humans are needed to determine this probiotic-enriched yogurt’s actual effects on gut health.

From your dietary perspective, are these new probiotic products worth considering?

Remember that food is primarily intended to provide us with nutrients, vitamins and minerals. Coconut dairy, like yogurt, does not have high nutritional density 1, 3.

While this probiotic-rich yogurt presents an innovative approach to delivering beneficial bacteria, its high-fat content, low protein levels, and cost should be considered when recommending it as a dietary option 2, 6. Traditional probiotic-rich foods, such as yogurt, kefir, and fermented vegetables, provide similar benefits with a more balanced nutritional profile. A varied and balanced diet, low in processed foods and rich in vegetables, fruits, whole grains, and legumes, supports microbiome diversity.

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Expert opinion Off

Vaginal microbiota #23

By Pr. Satu. Pekkala
Academy of Finland Research Fellow, Faculty of Sport,
and Health Science, University of Jyväskylä, Finland

Transgender women: a specific neovaginal flora

Some transgender women correct the gender incongruity of feeling like a woman in the depth of their being despite the physical presence of male genitalia and being referred to as a man by undergoing “penile inversion vaginoplasty.” In other words, by surgically transforming their penis into a vagina. However successful the surgery, the skin of this newly constructed vagina will combine skin from the penis and a skin graft from the scrotum and/or other area (s) (stomach, groin, etc.). How does this affect health? Vaginal microbiota makes a crucial contribution to good vaginal health in cisgender women.

And American researchers have now turned their attention to the intimate flora of transgender women undergoing surgery: might the composition of neovaginal microbiota explain certain problems, including the frequently reported issue of vaginal discharge? It is a question worth asking, and one that has now been answered thanks to a study comparing the vaginal microbiota of transgender women undergoing vaginoplasty with that of cisgender women. The results? They have very different microbiota. The vaginal flora of cisgender women is not very diverse and is dominated largely by lactobacilli, which creates an acidic environment that repels pathogens. That of transgender women has less than 3% of these precious allies and is much more diverse. Diversity in the vagina is not a sign of good health; quite the opposite. It is observed in cisgender women suffering from bacterial vaginosis, which increases risk of sexually transmitted infections (including HIV/AIDS) and miscarriage.

How is this new microbial ecosystem created? Or more precisely, which bacteria make up the neovaginal microbiota of transgender women having undergone surgery? They result no doubt from the flora of the skin (penis, scrotum, etc.) used during surgery. However, oral-genital and genital-genital transmission also appears to be involved. In fact, the neovaginal flora of transgender women having undergone surgery has been shown to include bacterial species typical not only of the skin and digestive tract, but also of the mouth. Since sexual relations influence the likelihood of a bacterium called E. faecalis, there is also genital transfer.

On the other hand, while the proliferation of protective lactobacilli in cisgender women can be explained by hormones, the hormonal status of transgender women (comparable to that of cisgender women due to treatment) seemed to make no difference. Further studies on larger numbers of transgender women will be needed to better understand their neovaginal health.

Winston McPherson G, Goldstein Z, Salipante SJ, et al. The Vaginal Microbiome of Transgender and Gender Nonbinary Individuals. Transgend Health 2024; 9: 205-11.

Summary
Off
Sidebar
Off
Migrated content
Désactivé
Updated content
Désactivé
Hide image
Off
Press review Off